Evidence map›Paper›PMID 24319286›Full record

ArticleJournal of leukocyte biology2014

Modification of heparanase gene expression in response to conditioning and LPS treatment: strong correlation to rs4693608 SNP.

Olga Ostrovsky, Avichai Shimoni, Polina Baryakh, Yan Morgulis, Margarita Mayorov, Katia Beider, Anna Shteingauz, Neta Ilan, Israel Vlodavsky, Arnon Nagler

Abstract read
In one paragraph

Article in Journal of leukocyte biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 18 citations in OpenAlex.

  1. The Pathophysiological Functions of Heparanases: From Evolution, Structural and Tissue-Specific Perspectives.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. The Heparanase Regulatory Network in Health and Disease.International journal of molecular sciences · 2021
    Review
  7. Article
  8. Article
  9. NK cell heparanase controls tumor invasion and immune surveillance.The Journal of clinical investigation · 2017
    Article
  10. Heparanase: From basic research to therapeutic applications in cancer and inflammation.Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy · 2016
    Review
  11. Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Olga Ostrovsky1.Dept. of Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel-Hashomer, Israel. olga.ostrovsky@sheba.health.gov.il.
Avichai Shimoni
Polina Baryakh
Yan Morgulis
Margarita Mayorov
Katia Beider
Anna Shteingauz
Neta Ilan
Israel Vlodavsky
Arnon Nagler
Sheba Medical Center · IL

Funding

Regulation of heparanase in cancer progressionR01CA106456 · NCI · TECHNION-ISRAEL INSTITUTE OF TECHNOLOGY · PI VLODAVSKY, ISRAEL · 2004 to 2013
$1.7M
NCI NIH HHS R01 CA106456NCI NIH HHS R01-CA106456
6 · The paper itself

Abstract

Heparanase is an endo-β-glucuronidase that specifically cleaves the saccharide chains of HSPGs, important structural and functional components of the ECM. Cleavage of HS leads to loss of the structural integrity of the ECM and release of HS-bound cytokines, chemokines, and bioactive angiogenic- and growth-promoting factors. Our previous study revealed a highly significant correlation of HPSE gene SNPs rs4693608 and rs4364254 and their combination with the risk of developing GVHD. We now demonstrate that HPSE is up-regulated in response to pretransplantation conditioning, followed by a gradual decrease thereafter. Expression of heparanase correlated with the rs4693608 HPSE SNP before and after conditioning. Moreover, a positive correlation was found between recipient and donor rs4693608 SNP discrepancy and the time of neutrophil and platelet recovery. Similarly, the discrepancy in rs4693608 HPSE SNP between recipients and donors was found to be a more significant factor for the risk of aGVHD than patient genotype. The rs4693608 SNP also affected HPSE gene expression in LPS-treated MNCs from PB and CB. Possessors of the AA genotype exhibited up-regulation of heparanase with a high ratio in the LPS-treated MNCs, whereas individuals with genotype GG showed down-regulation or no effect on HPSE gene expression. HPSE up-regulation was mediated by TLR4. The study emphasizes the importance of rs4693608 SNP for HPSE gene expression in activated MNCs, indicating a role in allogeneic stem cell transplantation, including postconditioning, engraftment, and GVHD.

Indexed as

Hematopoietic Stem Cell TransplantationPolymorphism, Single NucleotideTransplantation ConditioningAdolescentAdultAgedFemaleGenotypeGlucuronidaseGraft vs Host DiseaseHeparanaseHumansLeukocytes, MononuclearLipopolysaccharidesMaleMiddle AgedGlucuronidaseHeparanaseLipopolysaccharidesTLR4 protein, humanToll-Like Receptor 4acute GVHDallogeneic HSCTHPSEmononuclear cellsneutrophils

Identifiers

PMID24319286
PMCPMC4046248
OpenAlexW2100069865

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.